Federal award
INO THERAPEUTICS LLC
W81K0021F0014
Contract
Obligated and Ceiling
- Obligated (net)
- $2,149,648.86
- Ceiling (potential value, not spending)
- $2,736,038.86
- Current value
- $2,736,038.86
- Gross positive obligations
- $2,149,648.86
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81K0021F0014
- Parent vehicle (IDV PIID)
- V797D60737
- Award type code
- C
- Actions
- 13 · Dec 31, 2020 to Mar 6, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 6, 2025 | FY2025 | P00012 | M | $0.00 | — |
| Jan 8, 2025 | FY2025 | P00011 | C | $282,940.00 | — |
| Jun 21, 2024 | FY2024 | P00010 | G | $0.00 | — |
| Jan 3, 2024 | FY2024 | P00009 | C | $326,410.00 | — |
| Oct 26, 2023 | FY2024 | P00008 | G | $0.00 | — |
| Feb 27, 2023 | FY2023 | P00007 | C | $272,370.00 | — |
| Dec 22, 2022 | FY2023 | P00006 | G | $109,472.64 | — |
| May 27, 2022 | FY2022 | P00005 | C | $347,060.00 | — |
| Feb 9, 2022 | FY2022 | P00004 | M | $0.00 | — |
| Nov 23, 2021 | FY2022 | P00003 | C | $293,195.00 | — |
| Sep 2, 2021 | FY2021 | P00002 | B | $518,201.22 | — |
| Jul 26, 2021 | FY2021 | P00001 | G | $0.00 | — |
| Dec 31, 2020 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.